These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1647557)

  • 1. Extrapulmonary cytomegalovirus disease in transplant patients.
    Petersen EA
    Transplant Proc; 1991 Apr; 23(2 Suppl 1):13-6. PubMed ID: 1647557
    [No Abstract]   [Full Text] [Related]  

  • 2. Foscarnet therapy of ganciclovir-resistant cytomegalovirus in marrow transplantation.
    Drobyski WR; Knox KK; Carrigan DR; Ash RC
    Transplantation; 1991 Jul; 52(1):155-7. PubMed ID: 1650043
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytomegalovirus infections in transplant patients].
    Charpentier B
    Presse Med; 1991 Jun; 20(24):1107-8. PubMed ID: 1649473
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of cytomegalovirus pneumonia in transplant patients.
    Reed EC
    Transplant Proc; 1991 Apr; 23(2 Suppl 1):8-12. PubMed ID: 1647562
    [No Abstract]   [Full Text] [Related]  

  • 5. Foscarnet versus ganciclovir in the management of cytomegalovirus disease in patients with AIDS.
    Minor JR
    Am J Hosp Pharm; 1991 Nov; 48(11):2478-9. PubMed ID: 1660675
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cytomegalovirus infection in patients after lung transplantation].
    Cerrina J; Le Roy Ladurie F
    Presse Med; 1992 Mar; 21(11):503-6. PubMed ID: 1315436
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitivity of cytomegalovirus to intravenous foscarnet treatment.
    Akesson-Johansson A; Lernestedt JO; Ringdén O; Lönnqvist B; Wahren B
    Bone Marrow Transplant; 1986 Dec; 1(2):215-20. PubMed ID: 2844334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foscarnet prophylaxis in marrow transplant recipients.
    Ringden O; Lonnqvist B; Aschan J; Sundberg B
    Bone Marrow Transplant; 1989 Nov; 4(6):713. PubMed ID: 2555006
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of Cytomegalovirus infection].
    Leport C; Salmon D
    Rev Prat; 1990 Feb; 40(6):566-7. PubMed ID: 2157272
    [No Abstract]   [Full Text] [Related]  

  • 10. Problems in the management of cytomegalovirus infection in patients with AIDS.
    Connolly GM; Nelson MR; Barton SE; Gazzard BG
    Int J STD AIDS; 1991; 2(6):405-10. PubMed ID: 1664242
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy of cytomegalovirus infections with ganciclovir: a critical appraisal.
    Collier AC; Corey L
    Curr Clin Top Infect Dis; 1992; 12():309-28. PubMed ID: 1322676
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of cytomegalovirus infections in immunosuppressed patients].
    Michon C; Girard PM; Ngovan P; Simonpoli AM; Le Hoang P
    Ann Med Interne (Paris); 1988; 139(7):511-5. PubMed ID: 2854380
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients.
    Mattes FM; Hainsworth EG; Geretti AM; Nebbia G; Prentice G; Potter M; Burroughs AK; Sweny P; Hassan-Walker AF; Okwuadi S; Sabin C; Amooty G; Brown VS; Grace SC; Emery VC; Griffiths PD
    J Infect Dis; 2004 Apr; 189(8):1355-61. PubMed ID: 15073671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention and treatment of cytomegalovirus infections after graft of allogenic bone marrow].
    Gluckman E; McMazeron ; Keable H; Meletis J; Bombail D; Jolivet I; Huart JJ; Nebout T; Cavazzana M; De Castro H
    Nouv Rev Fr Hematol (1978); 1987; 29(1):17-21. PubMed ID: 3035485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
    Razonable RR; Rivero A; Rodriguez A; Wilson J; Daniels J; Jenkins G; Larson T; Hellinger WC; Spivey JR; Paya CV
    J Infect Dis; 2001 Dec; 184(11):1461-4. PubMed ID: 11709790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus infections in renal, heart, heart-lung and liver transplantation.
    Pollard RB
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S97-102. PubMed ID: 2456512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus pneumonia: presentation, diagnosis, and treatment.
    Ljungman P
    Semin Respir Infect; 1995 Dec; 10(4):209-15. PubMed ID: 8668848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of cytomegalovirus infection.
    Meyers JD
    Am J Med; 1988 Aug; 85(2A):102-6. PubMed ID: 2841853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
    Reddy AJ; Zaas AK; Hanson KE; Palmer SM
    J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.